Copyright © 2005 The Royal College of Radiologists Published by Elsevier Ltd.
Review
Use of imaging in the management of malignant pleural mesothelioma
Received 26 January 2005;
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Malignant pleural mesothelioma (MPM) is an increasingly prevalent tumour. The death rate associated with MPM is predicted to peak in the next 10 years, although radiologists and clinicians will be encountering cases for the next few decades. Contrast-enhanced CT is an established technique for evaluating suspected malignant pleural disease, but MPM can be reliably diagnosed only by histological sampling. However, even with adequate sampling and the use of immunocytochemistry, histological diagnosis is known to be difficult; definitive diagnosis may involve a combination of clinical presentation, radiological and histological appearances. Percutaneous biopsy is a promising technique for sampling the pleura. In view of its pattern of growth, MPM is a challenging disease to image by any method, and it behaves quite differently from lung cancer. This review aims to highlight the practical aspects of assessing malignant pleural mesothelioma.
Keywords: Mesothelioma; Pleura; Computed tomography; CT; Biopsy
Article Outline
- Introduction
- Pleural anatomy and lymph node drainage
- First-line imaging techniques
- Image-guided biopsy
- Additional imaging techniques
- Staging and resectability
- Treatment options
- Radical surgery
- Postoperative appearances following radical surgery
- Assessing response to chemotherapy
- Conclusions
- References






E-mail Article
Add to my Quick Links

Cited By in Scopus (7)






